Korkut ULUCAN, Ph.D (Part Time)
Prof.
FENS / Molecular Biology and Genetics (English) (Part Time)
Rate Us
Research Areas
Moleküler Biyoloji
Genetik
Short CV
Korkut Ulucan is Associate Prof. in Marmara University, Faculty of Dentistry, Department of Medical Biology and Genetics. He is also an adjunct faculty member of Üsküdar University, Faculty of Engineering and Natural Sciences, Department of Molecular Biology and Genetics. He had his MSc and PhD from Marmara University, Faculty of Medicine, Department of Medical Biology and Genetics. He is still the academic advisor for Genigma Genetic Research Center, the first specialized biotechnology company focusing on sports and nutri- genetics. His interested topics are sports genomics, gene doping, obesity and nutria-genetics, personalized medicine and genetic counseling.
Projects > Projects
Total: 8
1
Sizofreni tanısı alan hastalarda ADRA2A rs1800544 polimorfizminin incelenmesi2025
2
Bipolar tanısı alan hastalarda ZNF804A (rs1344706) polimorfizminin incelenmesi2025
3
Otizm tanısı alan çocuklarda SHANK2 (rs10792565) polimorfizminin incelenmesi2025
4
Genotypical Analysis Project on personalized treatment for psychosis and for dependence on alcohol and other psychotropic substances.2025
5
Bipolar bozukluğu olan hastalarda Sirkadiyen genlerden CLOCK rs1801260 polimorfizminin incelenmesi2023
6
Nöropsikiyatrik Hastalıklardan Olan Otizm ve Bipolar Bozukluk’ta genotip- fenotip ilişkisinin değerlendirilmesi2024
7
Nörogenetik Hastalık Vakalarında Tanıya Yönelik Genetik Yatkınlık Paneli Çalışması2022
8
Nöropsikiyatrik Hastalıklarda Genotip- Fenotip İlişkisinin Değerlendirilmesi (Evaluation of Genotype - Phenotype Relationship in Neuropsychiatric Diseases)2022
Academic Activities > Congress - Conference Participation
Total: 20
1
Profesyonel Bisikletçilerde Kafein Metabolizmasıyla İlgili CYP1A2 rs762551 Gen Polimorfizminin Dağılımının Belirlenmesi2024
2
Profesyonel Bisikletçilerde MSTN rs1805086 Polimorfizminin Dağılımının İncelenmesi2024
3
Determination of genotype-phenotype relationship in individuals with schizophrenia2023
4
NÖROPSİKİYATRİK HASTALIKLARDA CYP2C9 POLİMORFİZİMLERİNİN ETKİLERİNİN BELİRLENMESİ2022
5
ALZHEIMER HASTALIĞINDA APOE (rs429358, rs7412) POLİMORFİZMLERİNİN DAĞILIMININ İNCELENMESİ2022
6
NÖROPSİKİYATRİK HASTALIKLARDA SLC6A4 (rs 6532) POLİMORFİZMİNİN ETKİSİNİN BELİRLENMESİ2022
7
NÖROPSİKİYATRİK HASTALIKLARDA CYP2C19 *1 (n/a), *2 (rs4244285), *3 (rs4986893), *4 (rs28399504), *5 (rs56337013), *6 (rs72552267), *7 (rs72558186), *8 (rs41291556), *9 (rs17884712), *10 (rs6413438), *17 (rs12248560) POLİMORFİZMLERİNİN BELİRLENMESİ2022
8
NÖROPSİKİYATRİK HASTALIKLARDA CYP2D6*2 (rs16947), *3 (rs35742686), *4 (rs3892097), *6 (rs5030655), *7 (rs5030867), *8 (rs5030865-1), *9 (rs5030656), *10 (rs1065852), *12 (rs5030862), *14 (rs5030865-2), *17 (rs28371706), *41 (rs28371725) POLİMORFİZMLERİNİN2022
9
PSİKİYATRİK HASTALIKLARDA 5 HTT (SLC6A4) GENİ GENOTİPLEME SONUÇLARI2020
10
Geç-Yaş Alzheimer Hastalığı Tanısı Almış Türk Hastalarda APOE Genotiplemesi2020
11
ALZHEİMER HASTALIĞINDA ROLÜ OLAN BETA SEKRETAZ GENİNİN (BACE1) IN SILICO ANALİZİ2019
12
Psikiyatride Farmakogenetik Uygulamalrı2019
13
BİLGİSAYAR TABANLI YAZILIM ARAÇLARI İLE APH1B GENİNDEKİ FONKSİYONEL SNP’LERİN TAHMİN EDİLMESİ2018
14
The Effect of Dopamine D2 Receptor Taq A1 Allele on Sprinter and Endurance Athlete2018
15
CYP2D6 genetic profile of patients under major deppression treatment in a neuropysgciatry hospital in Istanbul, Increasing the Safety and Effectiveness of Personalized Therapy for Metabolic Disorders2015
16
Distribution of SLC6A4 L/S polymorphism in patients with depression, and impact of the allelles on optimal dosage for treatment, Increasing the Safety and Effectiveness of Personalized Therapy for Metabolic Disorders2015
17
Determination of CYP2C19 genotype in patients under depression treatment, Increasing the Safety and Effectiveness of Personalized Therapy for Metabolic Disorders2015
18
CYP1A2 genotype mat interfere in patients with drug medication, Increasing the Safety and Effectiveness of Personalized Therapy for Metabolic Disorders2015
19
CYP2C9 *1/*1 is dominating genotype in patients with major depression, Increasing the Safety and Effectiveness of Personalized Therapy for Metabolic Disorders2015
20
Classification of Schizophrenia patients by using multilayer perception neural network: A data mining approaches2015
Education and Teaching Activities
Total: 1
1